Open AccessRisk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension
Author(s) -
P. Bartenstein,
Stéphanie Saxer,
Paula Appenzeller,
Mona Lichtblau,
Esther I. Schwarz,
Silvia Ulrich
Publication year - 2018
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000488000
Subject(s) - medicine , pulmonary hypertension , chronic thromboembolic pulmonary hypertension , natriuretic peptide , cardiology , hemodynamics , heart failure
The latest pulmonary hypertension (PH) guidelines define therapeutic goals in terms of symptoms, exercise capacity, and haemodynamics for patients with pulmonary arterial hypertension (PAH) and recommend advanced combined medical therapy. For inoperable or post-surgical residual distal chronic thromboembolic PH (CTEPH) medical treatment is similarly advised.